Fmoc And Boc: Two Protecting-Group Strategies
Fmoc and Boc are the two temporary protecting groups used on the alpha-amino nitrogen during solid-phase peptide synthesis. Fmoc is removed by a base, conventionally 20% piperidine in dimethylformamide, and Boc is removed by an acid, conventionally 50% trifluoroacetic acid in dichloromethane. Everything else about the two routes, the resin, the side-chain protection, the final cleavage reagent and the characteristic impurity profile, follows from that one difference.
Solid-phase synthesis builds a chain one residue at a time on an insoluble support. Each cycle has two steps: remove the temporary protecting group from the nitrogen at the growing end, then couple the next protected amino acid onto the nitrogen that has just been freed. For the cycle to be repeatable, the temporary group has to come off under conditions that leave the side-chain protection and the link to the resin untouched.
Solid-phase synthesis achieves that in one of two ways. Fmoc chemistry relies on orthogonality: the temporary group is base-labile and everything else is acid-labile, so the two removals use chemically unrelated reagents. Boc chemistry achieves it by graded acid strength instead: the temporary group comes off in moderate acid and the side chains and resin link need strong acid, historically anhydrous hydrogen fluoride. That is why Fmoc became the default for most synthesis, including nearly all research-scale work.
The two cycles side by side
| Step | Fmoc strategy | Boc strategy |
|---|---|---|
| Temporary group removed by | Base: 20% piperidine in DMF, 2 exposures of 5 to 10 min | Acid: 25 to 50% TFA in dichloromethane, 20 to 30 min |
| Side-chain protection | Acid-labile: tBu, Trt, Pbf, Boc | Strongly acid-labile or benzyl-type: Bzl, Tos, cHx |
| Resin link | Acid-labile: Wang, Rink amide, 2-chlorotrityl | Benzyl ester or PAM on polystyrene |
| Final cleavage | 95% TFA with scavengers, 1 to 3 h at room temperature | Anhydrous HF or TFMSA, 0 °C, 60 to 90 min |
| Removal monitored by | Dibenzofulvene adduct absorbance at 301 nm | No comparable direct chromophore; colour tests on the resin |
The 301 nm readout is a practical advantage that is easy to overlook. Piperidine displaces the Fmoc group as dibenzofulvene, which forms an adduct with a strong absorbance band, so the completeness of each removal can be followed in real time on the flow-through. Boc removal releases isobutylene and carbon dioxide and offers nothing equivalent, so completeness is inferred from colourimetric tests on resin beads.
The failure mode: aspartimide formation under repeated base
The price of base-mediated removal is that every cycle exposes the whole chain to piperidine again. For a chain of 30 residues that is roughly 60 base exposures, and some sequences do not tolerate it. The characteristic problem is aspartimide formation: the side-chain ester of an aspartate residue is attacked by the backbone nitrogen of the residue that follows it, closing a five-membered succinimide ring and ejecting the side-chain protecting group.
Aspartimide formation does not end there: the ring opens again, and it opens two ways. One gives the intended alpha-linked chain back, the other gives a beta-linked isomer, and piperidine can also open it to a piperidide. The result is a set of by-products with the same or nearly the same mass as the target, which means mass spectrometry alone will not separate the story out. Asp-Gly, Asp-Asn and Asp-Arg pairings are the classic sensitive contexts, and reported aspartimide-derived by-product levels in a single unmitigated Asp-Gly sequence run into the tens of percent.
What the choice leaves behind in the powder
Both routes end in a trifluoroacetic-acid-containing step, which is why so much synthetic peptide arrives as a TFA salt. The counter-ion is not an impurity in the chromatographic sense. It is mass, commonly 5 to 20% w/w before any salt exchange, measured by ion chromatography or by fluorine-19 NMR rather than by HPLC.
- Fmoc route residues: piperidine traces, dibenzofulvene adducts, scavenger by-products from the cleavage cocktail such as triisopropylsilane and dithiothreitol derivatives.
- Boc route residues: alkylation adducts on electron-rich side chains, and handling constraints from hydrogen fluoride that keep the route out of most general-purpose laboratories.
- Common to both: deletion sequences from incomplete coupling, and truncated chains from premature cleavage. Neither is visible without a separation.
- Common to both: the counter-ion and residual solvent burden, which is mass-based and invisible at 214 nm.
The counter-ion burden is invisible at 214 nm, and so is much of what the route leaves behind. Boc chemistry, meanwhile, has not disappeared. It remains the better choice for some difficult targets, notably long hydrophobic sequences that aggregate on resin, and it is the basis of in-situ neutralisation methods developed for exactly that case. The reason it is uncommon at research scale is infrastructure: anhydrous hydrogen fluoride needs a dedicated apparatus and handling regime that Fmoc cleavage does not.
What Aurum can and cannot say about route
Synthetic route for the material we sell is not among the specifications Aurum publishes, and in most cases we are not told it. A certificate that reports chromatographic purity and identity by mass says nothing about whether a chain was built with Fmoc or Boc chemistry, and that is not something the published record can settle. Where a research question turns on the route, our documentation does not answer it.
What can be said is narrower and more useful: the impurity classes described above are sequence-dependent and route-dependent, and a purity figure expressed as area percent at a single wavelength does not resolve them. We report the figure we measure and not a conclusion about how the material came to be.
Common questions
Is one strategy more pure than the other?
Not in general. They fail on different sequences. A sequence rich in aspartate followed by glycine tends to be harder under Fmoc, and a sequence rich in tryptophan or methionine tends to be harder under repeated acid.
What does the word orthogonal mean here?
That two protecting groups are removed by chemically independent conditions, so one can be taken off without disturbing the other. Fmoc and tBu are orthogonal. Boc and benzyl are not orthogonal, only graded in acid lability.
Why is the removal step done twice in Fmoc chemistry?
Because a single exposure can leave a small fraction of the chain still protected, and any chain that is still protected will fail to couple in the next step and become a deletion sequence. Two shorter exposures push the removal further toward completion than one long one.
Does the route determine the counter-ion?
It determines the likely starting counter-ion, since both routes end in acid. It does not determine the final one, because salt exchange to acetate or hydrochloride can be performed afterwards and often is.
Can a chromatogram show which route was used?
No. A chromatogram shows which species are present and in what relative proportion. Attributing a given impurity peak to a route requires identification of that peak, not its retention time.
References
- 01Merrifield RB Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society, 1963.
- 02Carpino LA, Han GY The 9-fluorenylmethoxycarbonyl amino-protecting group. Journal of Organic Chemistry, 1972.
- 03Behrendt R, White P, Offer J Advances in Fmoc solid-phase peptide synthesis. Journal of Peptide Science, 2016.
- 04Schnölzer M, Alewood P, Jones A, Alewood D, Kent SB In situ neutralization in Boc-chemistry solid phase peptide synthesis. International Journal of Peptide and Protein Research, 1992.
- 05International Council for Harmonisation Q3C Impurities: Guideline for Residual Solvents. ICH Harmonised Guideline.
- 06United States Pharmacopeia General Chapter <1086> Impurities in Drug Substances and Drug Products. USP–NF.
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.